-
1
-
-
84954348364
-
Complement factor b production in renal tubular cells and its role in sodium transporter expression during polymicrobial sepsis
-
Li D, Zou L, Feng Y, Complement Factor B Production in Renal Tubular Cells and Its Role in Sodium Transporter Expression During Polymicrobial Sepsis. Crit Care Med 2016 44 e289 e299
-
(2016)
Crit Care Med
, vol.44
, pp. e289-e299
-
-
Li, D.1
Zou, L.2
Feng, Y.3
-
2
-
-
84888371687
-
Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis
-
Zou L, Feng Y, Li Y, Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis. J Immunol 2013 191 5625 5635
-
(2013)
J Immunol
, vol.191
, pp. 5625-5635
-
-
Zou, L.1
Feng, Y.2
Li, Y.3
-
3
-
-
66149084764
-
Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C
-
Goring K, Huang Y, Mowat C, Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C. Am J Physiol Cell Physiol 2009 296 C1140 C1150
-
(2009)
Am J Physiol Cell Physiol
, vol.296
, pp. C1140-C1150
-
-
Goring, K.1
Huang, Y.2
Mowat, C.3
-
4
-
-
84927592139
-
Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth
-
Coulthard LG, Woodruff TM, Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth. J Immunol 2015 194 3542 3548
-
(2015)
J Immunol
, vol.194
, pp. 3542-3548
-
-
Coulthard, L.G.1
Woodruff, T.M.2
-
5
-
-
84875990477
-
Complement in immune and inflammatory disorders: Therapeutic interventions
-
Ricklin D, Lambris JD, Complement in immune and inflammatory disorders: Therapeutic interventions. J Immunol 2013 190 3839 3847
-
(2013)
J Immunol
, vol.190
, pp. 3839-3847
-
-
Ricklin, D.1
Lambris, J.D.2
-
6
-
-
34047221398
-
Regulation of renal sodium transporters during severe inflammation
-
Schmidt C, Höcherl K, SchweDa F, Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 2007 18 1072 1083
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 1072-1083
-
-
Schmidt, C.1
Höcherl, K.2
SchweDa, F.3
-
7
-
-
62749206780
-
Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis
-
Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators
-
Trzeciak S, McCoy JV, Phillip Dellinger R, Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008 34 2210 2217
-
(2008)
Intensive Care Med
, vol.34
, pp. 2210-2217
-
-
Trzeciak, S.1
McCoy, J.V.2
Phillip Dellinger, R.3
-
8
-
-
0034861817
-
Extrahepatic synthesis of complement proteins in inflammation
-
Laufer J, Katz Y, Passwell JH, Extrahepatic synthesis of complement proteins in inflammation. Mol Immunol 2001 38 221 229
-
(2001)
Mol Immunol
, vol.38
, pp. 221-229
-
-
Laufer, J.1
Katz, Y.2
Passwell, J.H.3
-
9
-
-
84890226478
-
Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation
-
Liszewski MK, Kolev M, Le Friec G, Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 2013 39 1143 1157
-
(2013)
Immunity
, vol.39
, pp. 1143-1157
-
-
Liszewski, M.K.1
Kolev, M.2
Le Friec, G.3
-
10
-
-
78149477844
-
Molecular intercommunication between the complement and coagulation systems
-
Amara U, Flierl MA, Rittirsch D, Molecular intercommunication between the complement and coagulation systems. J Immunol 2010 185 5628 5636
-
(2010)
J Immunol
, vol.185
, pp. 5628-5636
-
-
Amara, U.1
Flierl, M.A.2
Rittirsch, D.3
-
11
-
-
84875244143
-
New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties
-
Qu H, Ricklin D, Bai H, New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. Immunobiology 2013 218 496 505
-
(2013)
Immunobiology
, vol.218
, pp. 496-505
-
-
Qu, H.1
Ricklin, D.2
Bai, H.3
|